10538
|
ETCTN
|
Venetoclax In Combination with ASTX727, an All-ORal TherapY for Chronic Myelomonocytic Leukemia and Other MDS/MPN with Excess Blasts (VICTORY-MDS/MPN): a Randomized, Phase 2 trial
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
10546
|
ETCTN
|
Phase I Study Targeting DNA Methyltransferases in Metastatic Triple-Negative Breast Cancer
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
10551
|
ETCTN
|
A Phase 1/1b Study of Anti-CD47 Hu5F9-G4 (Magrolimab) in Combination with Olaparib in Patients with BRCA1/2-mutant Tumors
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
10553
|
ETCTN
|
A Phase 2 Study of Darolutamide in Combination with Leuprolide Acetate in Hormone-Therapy Naïve Recurrent and/or Metastatic Androgen Receptor (AR) Positive Salivary Gland Cancer
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
10556
|
ETCTN
|
Randomized Phase 2 Study of Cabozantinib, Ipilimumab, and Nivolumab in Patients with Soft Tissue Sarcoma
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
10558
|
ETCTN
|
A Phase II Randomized Control Trial of Triapine Plus Lutetium Lu 177 Dotatate Versus Lutetium Lu 177 Dotatate Alone for Well-Differentiated Somatostatin Receptor-Positive Neuroendocrine Tumors
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
10559
|
ETCTN
|
A Phase 2 Study of Erdafitinib in Patients with Recurrent or Progressive IDH-Wild Type Glioma with an FGFR-TACC Gene Fusion
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
10561
|
ETCTN
|
Rapid Analysis and Response Evaluation of Combination Anti-neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 3 Tiragolumab + Atezolizumab
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
10563
|
ETCTN
|
A Phase 1 Study of Peposertib (M3814) and Low-Dose Liposomal Doxorubicin (Doxil®) in Patients with Metastatic Leiomyosarcoma and Other Soft Tissue Sarcomas
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
10572
|
ETCTN
|
A Phase 1/2 Trial Evaluating the Combination of Temozolomide and the Ataxia Telangiectasia and Rad3-related Inhibitor M1774
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|